MoneyWorks4Me

Eiko Lifesciences - Quaterly Results

12 Feb 2025 Evaluate
The Total revenue for the quarter ended December 2024 of  Rs. 69.11 millions remain, more or less, the same.Net profit stood at Rs. 2.84  millions  compared to Rs. 2.37 millions in the corresponding previous quarter,high by 19.83%.OP of the company witnessed a marginal growth to 5.58 millions from 4.77 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 69.11 66.11 4.54 254.00 195.32 30.04 279.29 183.21 52.44
Other Income 1.05 0.14 650.00 4.98 0.69 621.74 1.76 8.55 -79.42
PBIDT 5.58 4.77 16.98 16.92 11.62 45.61 17.88 18.10 -1.22
Interest 0.24 0.25 -4.00 0.89 1.20 -25.83 1.42 1.50 -5.33
PBDT 5.34 4.52 18.14 16.03 10.42 53.84 16.46 16.60 -0.84
Depreciation 1.54 1.61 -4.35 4.82 4.82 0.00 6.62 6.33 4.58
PBT 3.80 2.91 30.58 11.21 5.60 100.18 9.84 10.27 -4.19
TAX 0.96 0.54 77.78 2.83 1.24 128.23 2.32 2.57 -9.73
Deferred Tax 0.30 0.54 -44.44 0.85 1.24 -31.45 1.34 2.09 -35.89
PAT 2.84 2.37 19.83 8.38 4.36 92.20 7.52 7.70 -2.34
Equity 128.73 99.80 28.99 128.73 99.80 28.99 128.73 83.16 54.80
PBIDTM(%) 8.07 7.22 11.90 6.66 5.95 11.97 6.40 9.88 -35.20
Peers
Company Name CMP
Godrej Industries 1021.20
SRF 2490.00
BASF India 3411.40
Pidilite Inds. 1470.00
Tata Chemicals 607.90
View more..